Keywords: ضد انعقاد، پادبند; Hemodialysis; rivaroxaban; anticoagulant; anti-FXa activity; atrial fibrillation; stroke; end-stage renal disease (ESRD); area under the curve (AUC); pharmacokinetics; pharmacodynamics; dose finding; dose adjustment; dosing guideline;
مقالات ISI ضد انعقاد، پادبند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد انعقاد، پادبند; Anticoagulant; Renal function; Dosing; Atrial fibrillation; Anticoagulante; Función renal; PosologÃa; Fibrilación auricular; AF; atrial fibrillation; CG; Cockcroft-Gault; CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration; GFR; glomerular filtr
Keywords: ضد انعقاد، پادبند; Venous thromboembolism; Anticoagulant; Antiplatelet; Deep vein thrombosis; Pulmonary embolism;
Keywords: ضد انعقاد، پادبند; anticoagulant; antiplatelet; apixaban; blood thinners; dabigatran; dermatologic surgery; dietary supplements; prasugrel; rivaroxaban; ticagrelorADP, adenosine diphosphate; AF, atrial fibrillation; CVA, cerebrovascular accident; FDA, Food and Drug Administ
Keywords: ضد انعقاد، پادبند; Flavonoid; Anti-cancer; Anticoagulant; Hesperetin;
Keywords: ضد انعقاد، پادبند; Anticoagulant; Drug Side Effect; PPI; H2RA; AF; atrial fibrillation; CDARS; Hong Kong Clinical Data Analysis and Reporting System; CI; confidence interval; CMS; Clinical Management System; GIB; gastrointestinal bleeding; HA; Hospital Authority; HKW; Hong
Keywords: ضد انعقاد، پادبند; Surgical stress; Hypercoagulability; Venous thromboembolism; Anticoagulant; Heparin; Aspirin; Bleeding; Bridging;
Keywords: ضد انعقاد، پادبند; Sturgeon; Chondroitin sulfate; Anticoagulant; Anti-platelet aggregation; Thrombolysis;
Keywords: ضد انعقاد، پادبند; Anticoagulant; Concerns; Knowledge; Medication adherence; Satisfaction; Warfarin;
Keywords: ضد انعقاد، پادبند; Adhesion; Protamine sulfate; Anticoagulant; Antithrombine; Antidote
Keywords: ضد انعقاد، پادبند; Antiplatelet; Anticoagulant; Venous thromboembolism
Keywords: ضد انعقاد، پادبند; Biopsie; Anticoagulant; Lambeau bilobé; Cicatrisation; Biopsy; Antithrombotic treatment; Bilobed flap; Scarring;
Keywords: ضد انعقاد، پادبند; AC; Anticoagulant; ALL; Acute lymphoblastic leukemia; CSF; Cerebrospinal fluid; GEE; Generalized estimating equations; LMWH; Low molecular weight heparin; LP; Lumbar puncture; RBC; Red blood cells; UFH; Unfractionated heparin;
Keywords: ضد انعقاد، پادبند; Heparin; Heparan sulfate; Hemorrhagic activity; Antithrombin; Anticoagulant; Thermostabilization;
Keywords: ضد انعقاد، پادبند; Intracerebral hemorrhage; antiplatelet; anticoagulant; clinical outcome;
Keywords: ضد انعقاد، پادبند; Factor Xa; Anticoagulant; Conjugation; Docking study;
Keywords: ضد انعقاد، پادبند; low molecular weight heparin; heparin lyase; ultrafiltration; anticoagulant; NMR; mass spectrometry; surface plasmon resonance; polymeric drugs; structure-activity relationship; enzymes;
Keywords: ضد انعقاد، پادبند; Agarose; Carrageenan; Sulfation; Oligosaccharide; Anticoagulant; Cytotoxicity;
Keywords: ضد انعقاد، پادبند; Anticoagulant; Rodenticide; Primary poisoning; Rodent; Bait;
Keywords: ضد انعقاد، پادبند; anticoagulant; antiplatelet; heart failureACE, angiotensin-converting enzyme; ACS, acute coronary syndromes; ADP, adenosine diphoshpate; AF, atrial fibrillation; CAD, coronary artery disease; CI, confidence interval; F, circulating coagulation factor; GP,
Keywords: ضد انعقاد، پادبند; Fucoidans; Laminaran; Sulfated galactans; Oversulfation; Antioxidant; Anticoagulant
Keywords: ضد انعقاد، پادبند; Anticoagulant; Antiplatelet; Periprocedural; Atrial fibrillation; CHA2DS2-VASc;
Keywords: ضد انعقاد، پادبند; Bleeding; Thrombocytopenia; Coagulopathy; Anticoagulant; Hemorrhage; Hemostasis; Transfusion; Emergency;
Keywords: ضد انعقاد، پادبند; Antiplatelet; Anticoagulant; Hematoma;
Keywords: ضد انعقاد، پادبند; Rodenticide; Anticoagulant; Raptor; Poisoning;
Keywords: ضد انعقاد، پادبند; Aplastic anaemia; Anticoagulant; Chronic subdural haematoma; Posterior fossa; Thrombocytopenia;
Keywords: ضد انعقاد، پادبند; anticoagulant; claims analysis; hemorrhage; managed care; risk assessment;
Keywords: ضد انعقاد، پادبند; anticoagulant; dabigatran; rivaroxaban; bleeding; antidote;
Keywords: ضد انعقاد، پادبند; Polymannuronate; Polyguluronate; Polyanionic derivatives; Heparinoid; Anticoagulant; FGFs/FGFR1c signaling
Keywords: ضد انعقاد، پادبند; Anticoagulant; Central venous catheter; Deep venous thrombosis; Pediatrics; Randomized controlled trial; Survey
Keywords: ضد انعقاد، پادبند; Stroke; atrial cardiopathy; cryptogenic; anticoagulant; prevention
Keywords: ضد انعقاد، پادبند; Ischemic stroke; thromboembolism; antithrombotic; anticoagulant; antiplatelet; withdrawal; discontinuation; survey
Keywords: ضد انعقاد، پادبند; Dabigatran; anticoagulant; ischemic stroke; intracerebral hemorrhage; pharmacokinetics; renal function
Keywords: ضد انعقاد، پادبند; PT, Prothrombin Time; APTT, Activated Partial Thromboplastin Time; μg/ml, micrograms per milliliters; DMSO, dimethyl sulfoxideMedicinal plants; Anticoagulant; PT; APTT; Cheminformatics
Keywords: ضد انعقاد، پادبند; Anticoagulant; Analytical methods; Rodenticides; Biological samples
Keywords: ضد انعقاد، پادبند; Hemostasis; Factor IX; Thrombin; Anticoagulant; Heparin; Factor IX-binding protein; Aptamer;
Design and synthesis of novel potent anticoagulant and anti-tyrosinase pyranopyrimidines and pyranotriazolopyrimidines: Insights from molecular docking and SAR analysis
Keywords: ضد انعقاد، پادبند; Pyranopyrimidines; Pyranotriazolopyrimidines; Anticoagulant; Anti-tyrosinase; Molecular docking; SAR;
Anticoagulants oraux et chirurgie de l'obstruction prostatique : stopper, relayer ou poursuivre ?
Keywords: ضد انعقاد، پادبند; Anticoagulants; Hyperplasie bénigne de prostate; Laser; Anticoagulant; Begnin prostatic hyperplasia; Laser;
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice
Keywords: ضد انعقاد، پادبند; Anticoagulant; Vitamin k antagonist; Apixaban; Non-valvular atrial fibrillation; Stroke;
Phytochemical contents and biological evaluation of Ruta chalepennsis L. growing in Saudi Arabia
Keywords: ضد انعقاد، پادبند; Phytochemical analysis; Medicinal plants; Ruta chalepensis; Antimicrobial; Antioxidant; Anticoagulant;
Iatrogénie cutanée des traitements antithrombotiques
Keywords: ضد انعقاد، پادبند; anticoagulant; dermatoporose; hématome disséquant; héparine; nécrose cutanée; anticoagulant; deep dissection hematoma; dermatoporosis; heparin; skin necrosis;
Manejo del tratamiento antitrombótico en cirugÃa cardiovascular: puntualización sobre el Documento de Consenso acerca del manejo perioperatorio y periprocedimiento del tratamiento antitrombótico
Keywords: ضد انعقاد، پادبند; Tratamiento antitrombótico; Antiagregante; Anticoagulante; Manejo perioperatorio; Antithrombotic treatment; Anti-platelet; Anticoagulant; Perioperative management;
Haemostatic agent etamsylate in vitro and in vivo antagonizes anti-coagulant activity of heparin
Keywords: ضد انعقاد، پادبند; Heparin; Anticoagulant; Etamsylate; Anti-hemorrhagic; Haemostasia; Vasodilation;
Ischaemic heart disease: management of non-ST elevation acute coronary syndrome
Keywords: ضد انعقاد، پادبند; Acute coronary syndrome; anticoagulant; antiplatelet therapy; coronary angiography; coronary artery bypass surgery; MRCP; myocardial infarction; percutaneous coronary intervention; unstable angina;
An anticoagulant fucan sulfate with hexasaccharide repeating units from the sea cucumber Holothuria albiventer
Keywords: ضد انعقاد، پادبند; Fucan sulfate; Chemical structure; Anticoagulant; Polysaccharide; Sea cucumber;
Antithrombotic components of Malus halliana Koehne flowers
Keywords: ضد انعقاد، پادبند; Malus halliana flowers; Chemical composition; Column chromatography; Anticoagulant; Antithrombotic; APTT; activated partial thrombin time; PT; prothrombin time; TT; thrombin time; FIB; fibrinogen; WBV; whole blood viscosity; PV; plasma viscosity; HCT; hem
Antithrombotic potential of esculin 7, 3â², 4â², 5â², 6â²-O-pentasulfate (EPS) for its role in thrombus reduction using rat thrombosis model
Keywords: ضد انعقاد، پادبند; Anticoagulant; Serpin; Thrombosis; Antithrombin; Sulfated esculin;
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generation
Keywords: ضد انعقاد، پادبند; Anticoagulant; Dabigatran; Idarucizumab; Thrombin generation;
Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding
Keywords: ضد انعقاد، پادبند; Anticoagulant; Blood coagulation; Factor Xa inhibitor; Hemostasis; Thrombosis;
Structural analysis and anticoagulant activities of three highly regular fucan sulfates as novel intrinsic factor Xase inhibitors
Keywords: ضد انعقاد، پادبند; Fucan sulfate; Chemical structure; Anticoagulant; Polysaccharide; Sea cucumber;